Aphton Corporation to Present at the Harris Nesbitt Focus on Healthcare Conference.PHILADELPHIA -- Aphton Corporation (Nasdaq:APHT APHT Advance Physical Test ) announced today that Patrick Mooney, M.D., Chief Executive Officer and President, is scheduled to present at Harris Nesbitt Focus on Healthcare Conference at 9:30 a.m. EST EST electroshock therapy. EST abbr. electroshock therapy on Wednesday, December 8, 2004 at the Metropolitan Club in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . The audio transmission of the presentation will be available live and by replay on Aphton's website at http://www.aphton.com. The replay of the presentation will be available on Aphton's website beginning on Friday, December 10, 2004 for two weeks through Friday, December 24, 2004. About Aphton Corporation Aphton Corporation is a clinical stage biopharmaceutical company developing targeted immunotherapies for cancer and other diseases. The Company's products neutralize hormones involved in the growth and proliferation of cancers of the gastrointestinal system gastrointestinal system: see digestive system. and reproductive system reproductive system, in animals, the anatomical organs concerned with production of offspring. In humans and other mammals the female reproductive system produces the female reproductive cells (the eggs, or ova) and contains an organ in which development of the fetus , as well as other diseases. Aphton has strategic alliances with Aventis Pasteur for treating gastrointestinal system and other cancers with INSEGIA in North America and Europe; GlaxoSmithKline for reproductive system cancer and non-cancer diseases worldwide; Daiichi Pure Chemicals for the development, manufacturing and commercialization of gastrin-related diagnostic kits; Xoma for treating gastrointestinal and other gastrin-sensitive cancers using anti-gastrin monoclonal and other antibodies; and others. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion